Actavis rescues Allergan with $66 billion deal
Tuesday, November 25, 2014 - 07:03
in Mathematics & Economics
Deal ends takeover fight with Valeant – but Actavis must still be ‘fairly ruthless’ to justify the high price
Updated by artificial intelligence Thu, 13 Mar 2025, 3:35:01 UTC Learn more
- Tell your friends
- Get science news via